A Novel Prognostic Index Model for Adult Hemophagocytic Lymphohistiocytosis: A Multicenter Retrospective Analysis in China
Ziyuan Shen,Yingliang Jin,Qian Sun,Shuo Zhang,Xi Chen,Lingling Hu,Chenlu He,Ying Wang,Qinhua Liu,Hao Zhang,Xin Liu,Ling Wang,Jun Jiao,Yuqing Miao,Weiying Gu,Fei Wang,Chunling Wang,Yuye Shi,Jingjing Ye,Taigang Zhu,Cai Sun,Xuguang Song,Linyan Xu,Dongmei Yan,Haiying Sun,Jiang Cao,Depeng Li,Zhenyu Li,Zhao Wang,Shuiping Huang,Kailin Xu,Wei Sang
DOI: https://doi.org/10.3389/fimmu.2022.829878
IF: 7.3
2022-02-18
Frontiers in Immunology
Abstract:Hemophagocytic lymphohistiocytosis (HLH) is an immune disorder with rapid progression and poor survival. Individual treatment strategy is restricted, due to the absence of precise stratification criteria. In this multicenter retrospective study, we aimed to develop a feasible prognostic model for adult HLH in China. A total of 270 newly diagnosed patients of adult HLH were retrieved from the Huaihai Lymphoma Working Group (HHLWG), of whom 184 from 5 medical centers served as derivation cohort, and 86 cases from 3 other centers served as validation cohort. X-Tile program and Maxstat analysis were used to identify optimal cutoff points of continuous variables; univariate and multivariate Cox analyses were used for variable selection, and the Kaplan–Meier curve was used to analyze the value of variables on prognosis. The C-index, Brier Score, and calibration curve were used for model validation. Multivariate analysis showed that age, creatinine, albumin, platelet, lymphocyte ratio, and alanine aminotransferase were independent prognostic factors. By rounding up the hazard ratios from 6 significant variables, a maximum of 9 points was assigned. The final scoring model of HHLWG-HPI was identified with four risk groups: low risk (≤3 pts), low-intermediate risk (4 pts), high-intermediate risk (5-6 pts), and high risk (≥7 pts), with 5-year overall survival rates of 68.5%, 35.2%, 21.3%, and 10.8%, respectively. The C-indexes were 0.796 and 0.758 in the derivation and validation cohorts by using a bootstrap resampling program. In conclusion, the HHLWG-HPI model provides a feasible and accurate stratification system for individualized treatment strategy in adult HLH.
immunology